ZYGOMYCOSIS

Clinical trials for ZYGOMYCOSIS explained in plain language.

Never miss a new study

Get alerted when new ZYGOMYCOSIS trials appear

Sign up with your email to follow new studies for ZYGOMYCOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

High-Dose antifungal drug tested against deadly zygomycosis

Disease control Completed

This Phase 2 trial tested a high dose (10 mg/kg/day) of the antifungal drug liposomal amphotericin B (Ambisome) in 40 people with zygomycosis, a rare but serious fungal infection. The goal was to see if the high dose could effectively control the infection after 4 weeks of treatm…

Matched conditions: ZYGOMYCOSIS

Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control

Last updated Jun 27, 2026 09:11 UTC

ZYGOMYCOSIS

Get alerted when new ZYGOMYCOSIS trials appear

High-Dose antifungal drug tested against deadly zygomycosis